Popular on TelAve
- Voices Rising Festival Celebrates Diversity in E. Islip, GRAMMY Governor LACHI performs!
- Dr. Stephen Shainbart, PHD, Highlights 5 Reasons to Discuss Family Therapy and Couples Counseling in Buffalo, NY
- Origination of Prince Oak's new alias and reasons of his change — the Eurasian Prince's newest nominal label is "Papa Eurasia"
- New Study Reveals Alarming Cardiac Risks Associated with Electroshock Treatment
- U.S. Beauty and Personal Care Market Booming with Rising Demand for Natural and Organic Products
- Tim O'Loughlin Appointed Chief Executive Officer of Vantiva and Co-opted as a Director of the Board
- Situ Ve Offers a New Perspective on Love Amid the Rising Passport Bro Movement
- BroadSource and Access4 Introduce UCPayd, a Game-Changing Communication Security Solution
- Bridge Cable Partners With Alarm.com To Expand Security Solutions
- Superior Thin Film Solar Panel Advancements Open Great Opportunities in the Rapidly Developing Aerospace and Related Sectors: Stock Symbol: ASTI
Similar on TelAve
- Transform Your Date Night with Lick Pineapple Flavored Massage Oil – The Perfect Gift for New Relationships
- Alessia Moccia of E-uphoria: Bridging Fashion, Art, and Technology in NYC
- Healthcare Consulting Firm, Coker, Announces Acquisition of NorthGauge Healthcare Advisors
- Drive for Gratitude Significantly Impacts Veterans Well-being
- Retired Navy SEAL Launches Barrett Strategic Leadership Group (BSLG)
- Tarrytown Expocare Pharmacy to Open Florida IDD Pharmacy
- CCHR Demands Apology, Compensation for Racist Mental Health and Eugenics Policies
- WE In The World, Supported By Robert Wood Johnson Foundation, Calls Healthcare & Community Changemakers To Transform Structural Racism in Healthcare
- Arbutus Medical Launches Digit Revision SwiftKit™ to Streamline Trauma Care and Improve Emergency Department Throughput
- Natural Sweetener Health Trend on the Rise: Black Friday Special Discounts Are Here!
Dr. Jeff Gelblum Provides Alzheimer's Treatment to Patients in the US and Abroad
TelAve News/10835940
AVENTURA, Fla. - TelAve -- Dr. Jeff Gelblum, Neurologist at First Choice Neurology, has brought together clinical, imaging, and laboratory capabilities to provide rapid diagnosis and treatment to individuals suffering from Alzheimer's disease.
The patient journey of Alzheimer's evaluation and management involves a clinical assessment to determine the level of cognitive impairment, and imaging studies of the brain, MRI, and PET scans to identify the presence of brain amyloid plaques. Also included are laboratory capabilities to inform the tolerability of the new anti-Alzheimer medication, and an experienced infusion team capable of providing the new class of FDA-approved medication in a comfortable setting.
Dr. Gelblum's highly integrated program will eliminate the long delays and fragmented care that typically plague patients seeking Alzheimer's treatment.
He observes, "that the new class of disease-modifying treatments are only approved in mild Alzheimer's which offers only a short window of opportunity to treat. In the US and abroad, it can often take up to a year to get a neurology appointment, and by that point, the patient may have progressed to a point where they might no longer respond to treatment."
More on TelAve News
Dr. Gelblum's program eliminates the delay and provides a quick and comprehensive work-up in the Aventura medical district, just north of Miami, Florida.
Dr. Gelblum boasts that "within 48 hours we can diagnose and begin infusion therapy. This means that the patient can check in to our on-campus hotel on a Tuesday evening, undergo evaluation in our clinic Wednesday morning, receive diagnostic testing Wednesday and Thursday, and then obtain their infusion treatment on Friday."
For those patients who reside out of town, his infusion center can dispense medication to-go for follow-up infusion treatments in their hometown medical facility. This is ideal for out-of-town patients who may not have easy access to a neurologist. He can then follow the patient remotely via telehealth.
His Aventura clinic is easily accessible via Miami or Fort Lauderdale international airports.
Dr. Gelblum has a global patient population who has discovered the ease of access and convenience of care provided by this program. He has patients from the UK, Spain, France, Israel, Russia, South Korea, Central and South America, and the Caribbean. They are diagnosed in his Aventura clinic and then followed up remotely via Skype, WhatsApp, FaceTime, or any manner of live audiovisual interface.
More on TelAve News
Dr. Gelblum observes, "that in this day and age of disease-modifying therapy and instantaneous telecommunications, it is unacceptable for medically necessary neurological care and treatment to be delayed."
He looks forward to welcoming Alzheimer patients from all over to his Aventura, Florida clinic.
About Jeffrey Gelblum, MD, FAAN
Dr. Jeff Gelblum is a neurologist with First Choice Neurology located in Aventura, Florida. He is considered a global thought leader in the neurologic treatment of Alzheimer's, dementia, seizure disorders, Parkinson's, diabetic and peripheral nerve disorder, Familial Amyloid Polyneuropathy, Covid Long-Hauler, trauma, and chronic pain, and has hosted educational symposia in the U.S. and overseas. To learn more about Dr. Gelblum, visit https://www.fcneurology.net/business-directory/788/jeffrey-gelblum-md/
The patient journey of Alzheimer's evaluation and management involves a clinical assessment to determine the level of cognitive impairment, and imaging studies of the brain, MRI, and PET scans to identify the presence of brain amyloid plaques. Also included are laboratory capabilities to inform the tolerability of the new anti-Alzheimer medication, and an experienced infusion team capable of providing the new class of FDA-approved medication in a comfortable setting.
Dr. Gelblum's highly integrated program will eliminate the long delays and fragmented care that typically plague patients seeking Alzheimer's treatment.
He observes, "that the new class of disease-modifying treatments are only approved in mild Alzheimer's which offers only a short window of opportunity to treat. In the US and abroad, it can often take up to a year to get a neurology appointment, and by that point, the patient may have progressed to a point where they might no longer respond to treatment."
More on TelAve News
- Anaptyx Recognized as First in Customer Service
- The United States Environmental Protection Agency (USEPA) is SEBAC's 2024 Award for Excellence winner
- Author Riley G. Staliger Offers Tools to Escape Guilt-Driven Relationships AKA Obligationships Using Pop Culture
- Healthcare Consulting Firm, Coker, Announces Acquisition of NorthGauge Healthcare Advisors
- Kaplan Morrell Named Exclusive Workers' Compensation Firm for Greeley Fire Fighters
Dr. Gelblum's program eliminates the delay and provides a quick and comprehensive work-up in the Aventura medical district, just north of Miami, Florida.
Dr. Gelblum boasts that "within 48 hours we can diagnose and begin infusion therapy. This means that the patient can check in to our on-campus hotel on a Tuesday evening, undergo evaluation in our clinic Wednesday morning, receive diagnostic testing Wednesday and Thursday, and then obtain their infusion treatment on Friday."
For those patients who reside out of town, his infusion center can dispense medication to-go for follow-up infusion treatments in their hometown medical facility. This is ideal for out-of-town patients who may not have easy access to a neurologist. He can then follow the patient remotely via telehealth.
His Aventura clinic is easily accessible via Miami or Fort Lauderdale international airports.
Dr. Gelblum has a global patient population who has discovered the ease of access and convenience of care provided by this program. He has patients from the UK, Spain, France, Israel, Russia, South Korea, Central and South America, and the Caribbean. They are diagnosed in his Aventura clinic and then followed up remotely via Skype, WhatsApp, FaceTime, or any manner of live audiovisual interface.
More on TelAve News
- Drive for Gratitude Significantly Impacts Veterans Well-being
- The Voice of the Wooden Dragon is Latest Release from NFB Publishing
- AONE Fest 2024: Celebrating Creativity and Community at Red Dot Studios
- At Your Service Plumbing Honored with Silver Award in The Best of Pierce County
- Retired Navy SEAL Launches Barrett Strategic Leadership Group (BSLG)
Dr. Gelblum observes, "that in this day and age of disease-modifying therapy and instantaneous telecommunications, it is unacceptable for medically necessary neurological care and treatment to be delayed."
He looks forward to welcoming Alzheimer patients from all over to his Aventura, Florida clinic.
About Jeffrey Gelblum, MD, FAAN
Dr. Jeff Gelblum is a neurologist with First Choice Neurology located in Aventura, Florida. He is considered a global thought leader in the neurologic treatment of Alzheimer's, dementia, seizure disorders, Parkinson's, diabetic and peripheral nerve disorder, Familial Amyloid Polyneuropathy, Covid Long-Hauler, trauma, and chronic pain, and has hosted educational symposia in the U.S. and overseas. To learn more about Dr. Gelblum, visit https://www.fcneurology.net/business-directory/788/jeffrey-gelblum-md/
Source: First Choice Neurology
0 Comments
Latest on TelAve News
- Arbutus Medical Launches Digit Revision SwiftKit™ to Streamline Trauma Care and Improve Emergency Department Throughput
- MarketTecNexus CEO's Digital Clone Introduces "AI Business Scale Up™," Services Redefining AI Transformation for Mid-Size Businesses
- Los Defensores Champions Underserved Communities with the Launch of "Siempre Contigo" Initiative in Houston
- Natural Sweetener Health Trend on the Rise: Black Friday Special Discounts Are Here!
- TOKYO SKYTREE® is Now Selling Premium Traditional Performing Arts Experiences
- Vantiva and e& Deploy First eSIM-enabled 5G Fixed Wireless Access Gateway for United Arab Emirates Subscribers
- OpsVeda Announces General Availability Of Release 10.0 Of Its AI Powered Operations Command Center
- Celebrate Christmas 2024 with Exclusive Deals and Festive Offers
- Klatt Works, Executive Flightways, L2 Aviation, and Ametek Revolutionize Business Jet Safety with the First SAVED System STC for the G550
- Bainbridge Custom Builders Launches to Redefine Custom Construction and Renovation in Philadelphia
- 76 FENCE Expands in North Carolina with Strategic Franchise Growth Led by Regional Developer Drew Myers
- See Our Earth Champions Environmental Education and Conservation Through Initiatives, Dad Hats and Mountain Hats
- NEW AI Launch! StarboxAI VI-Pro - Live Streaming System; Empowering 800 Merchants to Boost Sales to Over 2 Million Users: StarBox (Stock Symbol: STBX)
- El Ranchito Appoints New President
- Mrs Elemental® USA National Competition Introduces the Prestigious Panel of National Judges
- "House of War" Live Event & Podcast Series by Daniel Sadan Debuts This Week
- Balam and Transfera Unveil the World's First Remittance-as-a-Service Platform
- AI-driven money-saving tips: Black Friday shopping guide for 2024
- myStaze: Revolutionizing Live Music Streaming in the U.S. – Artists Earn 90% of Ticket Sales!
- Crosby Tatum's "The People, United" heads to Georgia & New York City during 2024 US General Election Season